Articles related to PEER-TO-PEER

A recent segment of the BBC’s Panorama program revealed that many NHS employees who contracted COVID-19—likely at work—now find themselves abandoned and in a perilous financial situation. The episode profiled NHS employees who are dealing with the long-term health impacts of the COVID-19 infection and revealed the experiences of those who, while being too ill to work, risk losing their jobs or receiving decreased sick pay. Some employees have already experienced this. This physician is one of them.

Reducing unneeded lab work in the hospital setting is a monumental task. It is a kind of security blanket, and it is automated in many EMRs. For clinicians, seeing that lab values are stable can be a reassurance while waiting for treatment to take effect. And everyone has their story of the one patient for whom a change in routine daily labs prompted urgent intervention.

OBR covers this New York Times opinion piece; many doctors are jumping on the bandwagon to point out where the cause of burnout truly lies.

This physician sounds the alarm on CDC’s ill-founded mandates for mandatory masking, citing the recent Cochrane Review.

There is much we don’t know because of weak surveillance methods. For informed decisions, medicine needs a better understanding of what is happening and what is working at any given time. Since even with 100% vaccination, the virus will at minimum continue in circulation, a key goal is to focus on those who are most at risk for severe disease and learn how to strengthen their immunity.

Marc R. Bloomenstein, OD, FAAO examines the status of various ophthalmic medications in the first video of 2023, including preservative-free latanoprost for IOP reduction (IYUZEH, Thea Pharma), MydCombi (Eyenovia) for in-office pupil dilatation, and others.